NCT03956134 - Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Pharmacokinetics

Interventions

DRUG

Tapentadol Test Product 1

Tapentadol tablet containing 116 mg of tapentadol hydrochloride; Tapentadol Test Product 1 contains different amounts of excipients than Tapentadol Test Product 2

DRUG

Tapentadol Test Product 2

Tapentadol tablet containing 116 mg of tapentadol hydrochloride; Tapentadol Test Product 2 contains different amounts of excipients than Tapentadol Test Product 1

DRUG

Tapentadol Prolonged-release Reference Product

Tapentadol PR tablet containing 116 mg of tapentadol hydrochloride

Trial Locations (1)

52099

Department of Clinical Pharmacology, Grünenthal GmbH, Aachen